A Phase III Study of BBI-608 in Combination With 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients With Previously Treated Metastatic Colorectal Cancer (CRC).
Phase of Trial: Phase III
Latest Information Update: 30 May 2018
At a glance
- Drugs Napabucasin (Primary) ; Bevacizumab; Fluorouracil; Folinic acid; Irinotecan
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Sponsors Boston Biomedical
- 10 Jun 2017 Biomarkers information updated
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 18 May 2017 According to a Boston Biomedical media release, data from this study will be presented at the 2017 American Society of Clinical Oncology (ASCO) annual meeting.